Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1467056, 8 pages
https://doi.org/10.1155/2017/1467056
Research Article

Influence of Men’s Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer

1School of Medicine, Department of Family Medicine and Public Health Sciences, Wayne State University, Detroit, MI, USA
2Department of Medicine, Michigan State University, East Lansing, MI, USA
3School of Medicine, Department of Anesthesiology, Wayne State University, Detroit, MI, USA

Correspondence should be addressed to Jinping Xu; ude.enyaw.dem@uxj

Received 31 March 2017; Revised 31 May 2017; Accepted 11 June 2017; Published 12 July 2017

Academic Editor: David B. Samadi

Copyright © 2017 Elyse Reamer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Cancer of the Prostate—Cancer Stat Facts,” http://seer.cancer.gov/statfacts/html/prost.html.
  2. “Survival Rates for Prostate Cancer,” https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/survival-rates.html.
  3. “Prostate Cancer Treatment,” https://www.cancer.gov/types/prostate/patient/prostate-treatment-pdq#section/_142.
  4. F. C. Hamdy, J. L. Donovan, J. A. Lane et al., “10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer,” The New England Journal of Medicine, vol. 375, no. 15, pp. 1415–1424, 2016. View at Publisher · View at Google Scholar
  5. I. Thompson, J. B. Thrasher, G. Aus et al., “Guideline for the management of clinically localized prostate cancer: 2007 update,” Journal of Urology, vol. 177, no. 6, pp. 2106–2131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Orom, L. A. Penner, B. T. West, T. M. Downs, W. Rayford, and W. Underwood, “Personality predicts prostate cancer treatment decision-making difficuty and satisfaction,” Psycho-Oncology, vol. 18, no. 3, pp. 290–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Mollica, W. Underwood, G. G. Homish, D. L. Homish, and H. Orom, “Spirituality is associated with better prostate cancer treatment decision making experiences,” Journal of Behavioral Medicine, vol. 39, no. 1, pp. 161–169, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Mollica, W. Underwood, G. G. Homish, D. L. Homish, and H. Orom, “Spirituality is associated with less treatment regret in men with localized prostate cancer,” Psycho-Oncology, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. S. B. Zeliadt, D. F. Penson, C. M. Moinpour et al., “Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer,” BJU International, vol. 108, no. 6, pp. 851–856, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Symes, L. Song, R. G. Heineman et al., “Involvement in decision making and satisfaction with treatment among partners of patients with newly diagnosed localized prostate cancer,” Oncology Nursing Forum, vol. 42, no. 6, pp. 672–679, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Mallapareddi, J. Ruterbusch, E. Reamer, S. Eggly, and J. Xu, “Active surveillance for low-risk localized prostate cancer: what do men and their partners think?” Family Practice, vol. 34, no. 1, pp. 90–97, 2017. View at Publisher · View at Google Scholar
  12. T. D. Denberg, B. L. Beaty, F. J. Kim, and J. F. Steiner, “Marriage and ethnicity predict treatment in localized prostate carcinoma,” Cancer, vol. 103, no. 9, pp. 1819–1825, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. D. Ramsey, S. B. Zeliadt, N. K. Arora et al., “Access to information sources and treatment considerations among men with local stage prostate cancer,” Urology, vol. 74, no. 3, pp. 509–515, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Chapple, S. Ziebland, A. Herxheimer, A. Mcpherson, S. Shepperd, and R. Miller, “Is ‘watchful waiting’ a real choice for men with prostate cancer? A qualitative study,” BJU International, vol. 90, no. 3, pp. 257–264, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. S. E. Wagner, B. F. Drake, K. Elder, and J. R. Hébert, “Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina,” Cancer Causes and Control, vol. 22, no. 11, pp. 1597–1606, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. K. M. Christie, B. E. Meyerowitz, A. Giedzinska-Simons, M. Gross, and D. B. Agus, “Predictors of affect following treatment decision-making for prostate cancer: conversations, cognitive processing, and coping,” Psycho-Oncology, vol. 18, no. 5, pp. 508–514, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Diefenbach, J. Dorsey, R. G. Uzzo et al., “Decision-making strategies for patients with localized prostate cancer,” Seminars in Urologic Oncology, vol. 20, no. 1, pp. 55–62, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. D. L. Berry, W. J. Ellis, K. J. Russell et al., “Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer,” Clinical Genitourinary Cancer, vol. 5, no. 3, pp. 219–226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Xu, J. Janisse, J. Ruterbusch, J. Ager, and K. L. Schwartz, “Racial differences in treatment decision-making for men with clinically localized prostate cancer: a population-based study,” Journal of Racial and Ethnic Health Disparities, vol. 3, no. 1, pp. 35–45, 2016. View at Publisher · View at Google Scholar
  20. K. Davis, P. Bellini, C. Hagerman et al., “Physicians’ perceptions of factors influencing the treatment decision-making process for men with low-risk prostate cancer,” Urology, 2017. View at Publisher · View at Google Scholar
  21. J. Xu, R. K. Dailey, S. Eggly, A. V. Neale, and K. L. Schwartz, “Men’s perspectives on selecting their prostate cancer treatment,” Journal of the National Medical Association, vol. 103, no. 6, pp. 468–478, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Xu, A. V. Neale, R. K. Dailey, S. Eggly, and K. L. Schwartz, “Patient perspective on watchful waiting/active surveillance for localized prostate cancer,” Journal of the American Board of Family Medicine, vol. 25, no. 6, pp. 763–770, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Dillman, Mail and Telephone Surveys—The Total Design Method, Wiley, New York, NY, USA, 1978.
  24. M. Holmes-Rovner, J. Kroll, N. Schmitt et al., “Patient satisfaction with health care decisions: the satisfaction with decision scale,” Medical Decision Making, vol. 16, no. 1, pp. 58–64, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. J. C. Brehaut, A. M. O'Connor, T. J. Wood et al., “Validation of a decision regret scale,” Medical Decision Making, vol. 23, no. 4, pp. 281–292, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Connolly and J. Reb, “Regret in cancer-related decisions,” Health Psychology, vol. 24, no. 4, pp. S29–S34, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. F. Scheier, C. S. Carver, and M. W. Bridges, “Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the life orientation test,” Journal of Personality and Social Psychology, vol. 67, no. 6, pp. 1063–1078, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. K. A. Wallston, B. S. Wallston, and R. DeVellis, “Development of the multidimensional health locus of control (MHLC) scales,” Health Education Monographs, vol. 6, no. 2, pp. 160–170, 1978. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Holmes-Rovner, J. S. Montgomery, D. R. Rovner et al., “Informed decision making: assessment of the quality of physician communication about prostate cancer diagnosis and treatment,” Medical Decision Making, vol. 35, no. 8, pp. 999–1009, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Xu, J. Janisse, J. J. Ruterbusch et al., “Patients’ survival expectations with and without their chosen treatment for prostate cancer,” Annals of Family Medicine, vol. 14, no. 3, pp. 208–214, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Stacey, F. Légaré, N. F. Col et al., “Decision aids for people facing health treatment or screening decisions,” The Cochrane Database of Systematic Reviews, no. 1, Article ID CD001431, 2014. View at Google Scholar · View at Scopus
  32. F. J. Fowler, M. McNaughton Collins, P. C. Albertsen, A. Zietman, D. B. Elliott, and M. J. Barry, “Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer,” Journal of the American Medical Association, vol. 283, no. 24, pp. 3217–3222, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. M. R. Cooperberg and P. R. Carroll, “Trends in management for patients with localized prostate cancer, 1990–2013,” JAMA—Journal of the American Medical Association, vol. 314, no. 1, pp. 80–82, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. T. L. Jang, J. E. Bekelman, Y. Liu et al., “Physician visits prior to treatment for clinically localized prostate cancer,” Archives of Internal Medicine, vol. 170, no. 5, pp. 440–450, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. B. D. Sommers, C. J. Beard, A. V. D'Amico, I. Kaplan, J. P. Richie, and R. J. Zeckhauser, “Predictors of patient preferences and treatment choices for localized prostate cancer,” Cancer, vol. 113, no. 8, pp. 2058–2067, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. K. A. Scherr, A. Fagerlin, T. Hofer et al., “Physician recommendations trump patient preferences in prostate cancer treatment decisions,” Medical Decision Making, vol. 37, no. 1, pp. 56–69, 2017. View at Publisher · View at Google Scholar
  37. K. L. Taylor, R. M. Hoffman, K. M. Davis et al., “Treatment preferences for active surveillance versus active treatment among men with low-risk prostate cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 25, no. 8, pp. 1240–1250, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. T. L. Krupski, L. Kwan, A. Fink, G. A. Sonn, S. Maliski, and M. S. Litwin, “Spirituality influences health related quality of life in men with prostate cancer,” Psycho-Oncology, vol. 15, no. 2, pp. 121–131, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Diiorio, K. Steenland, M. Goodman, S. Butler, J. Liff, and P. Roberts, “Differences in treatment-based beliefs and coping between African American and white men with prostate cancer,” Journal of Community Health, vol. 36, no. 4, pp. 505–512, 2011. View at Publisher · View at Google Scholar · View at Scopus